Company ClearPoint Neuro, Inc.

Equities

CLPT

US18507C1036

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for ClearPoint Neuro, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
5.26 ^USD	-0.94%		-1.31%	-22.53%

04-24	ClearPoint Neuro, Inc. Announces Initiation of Limited Market Release for the SmartFrame OR? Stereotactic System	CI
04-16	ClearPoint Neuro Says Partner AviadoBio Treats First Person in Trial of AVB-101 for Frontotemporal Dementia	MT

ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Companyâs flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Number of employees: 107

USD in Million	2022	Weight	2023	Weight	Delta
Biologics and Drug Delivery - Services and License 47.8 %	5	26.4 %	11	47.8 %	+110.83%
Functional Neurosurgery Navigation and Therapy - Disposable Products 31.7 %	8	36.9 %	8	31.7 %	+0.03%
Biologics and Drug Delivery - Disposable Products 9.0 %	4	18.0 %	2	9.0 %	-41.63%
Capital Equipment and Software - Services 4.1 %	1	3.9 %	1	4.1 %	+22.39%
Functional Neurosurgery Navigation and Therapy - Services 3.9 %	2	7.5 %	1	3.9 %	-39.43%
Capital Equipment and Software - Systems and Software Products 3.6 %	2	7.4 %	1	3.6 %	-43.12%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	21	100.0 %	24	100.0 %	+16.56%

Managers	Title	Age	Since
Joseph Burnett CEO	Chief Executive Officer	47	06/11/17
Danilo D’Alessandro DFI	Director of Finance/CFO	39	28/09/20
Mazin Sabra COO	Chief Operating Officer	44	09/10/22
Caroline Corner IRC	Investor Relations Contact	-	-
Jeremy Stigall PRN	Corporate Officer/Principal	41	30/06/20
Ellisa Cholapranee LAW	General Counsel	-	04/04/21
Jacqueline Keller SAM	Sales & Marketing	-	31/10/19
Mary McNamara-Cullinane LAW	General Counsel	-	-
Robert Korn SAM	Sales & Marketing	58	11/11/12
Chris Yelley PRN	Corporate Officer/Principal	-	31/12/11

Members of the board	Title	Age	Since
B. Johnson BRD	Director/Board Member	72	31/08/19
Lynnette Fallon BRD	Director/Board Member	64	14/07/21
R. Fletcher CHM	Chairman	78	08/05/17
Pascal Girin BRD	Director/Board Member	64	02/09/14
Timothy Richards BRD	Director/Board Member	66	09/03/14
Joseph Burnett CEO	Chief Executive Officer	47	06/11/17
Matthew Klein BRD	Director/Board Member	52	15/04/20
Linda Liau BRD	Director/Board Member	57	01/11/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	27,069,568	25,012,797 ( 92.40 %)	0	92.40 %

Name	Equities	%	Valuation
Michael Bigger 7.367 %	1,987,256	7.367 %	14 M $
BlackRock Advisors LLC 5.239 %	1,413,193	5.239 %	10 M $
Vanguard Fiduciary Trust Co. 4.851 %	1,308,694	4.851 %	9 M $
PTC THERAPEUTICS, INC. 3.316 %	894,578	3.316 %	6 M $
Geode Capital Management LLC 1.813 %	489,155	1.813 %	3 M $
Taylor Frigon Capital Management LLC 1.572 %	424,097	1.572 %	3 M $
STATE STREET CORPORATION 1.293 %	348,898	1.293 %	2 M $
Brown Investment Advisory & Trust Co. 1.236 %	333,395	1.236 %	2 M $
Joseph Burnett 0.9763 %	263,364	0.9763 %	2 M $
Cahill Wealth Management LLC 0.8610 %	232,263	0.8610 %	2 M $

Clearpoint Neuro, Inc.

120 South Sierra Avenue Suite 100

92075, Solana Beach

http://www.clearpointneuro.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.26 USD

Average target price

10 USD

Spread / Average Target

+90.11%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
CLEARPOINT NEURO, INC.	-22.53%	142M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology